Afamin is synthesized by cerebrovascular endothelial cells and mediates α‐tocopherol transport across an in vitro model of the blood–brain barrier

α‐Tocopherol (αTocH), a member of the vitamin E family, is essential for normal neurological function. Despite the importance of αTocH transport into the CNS, transfer mechanisms across the blood–brain barrier (BBB) are not entirely clear. We here investigate whether afamin, a known αTocH‐binding protein, contributes to αTocH transport across an in vitro model of the BBB consisting of primary porcine brain capillary endothelial cells (BCEC) and basolaterally cultured astrocytoma cells. Exogenously added afamin had no adverse effects on BCEC viability or barrier function and was transported across BCEC Transwell cultures. Furthermore, αTocH transport across polarized BCEC cultures to astrocytoma cells is facilitated by afamin, though to a lesser extent than by high‐density lipoprotein‐mediated transport, an essential and in vivo operating αTocH import pathway at the cerebrovasculature. We also demonstrate that porcine BCEC endogenously synthesize afamin. In line with these in vitro findings, afamin was detected by immunohistochemistry in porcine, human postmortem, and mouse brain, where prominent staining was observed almost exclusively in the cerebrovasculature. The demonstration of afamin mRNA expression in isolated brain capillaries suggests that afamin might be a new family member of binding/transport proteins contributing to αTocH homeostasis at the BBB in vivo.

[1]  M. Kuskowski,et al.  Deletion of apolipoprotein E gene modifies the rate of depletion of alpha tocopherol (vitamin E) from mice brains. , 2008, Biochimica et biophysica acta.

[2]  M. Dietrich,et al.  Megalin mediates the transport of leptin across the blood-CSF barrier , 2008, Neurobiology of Aging.

[3]  H. Leis,et al.  Endothelin (ET)‐1 and ET‐3 promote expression of c‐fos and c‐jun in human choriocarcinoma via ETB receptor‐mediated Gi‐ and Gq‐pathways and MAP kinase activation , 2008, British journal of pharmacology.

[4]  C. Cross,et al.  Mice lacking α-tocopherol transfer protein gene have severe α-tocopherol deficiency in multiple regions of the central nervous system , 2008, Brain Research.

[5]  Y. Moritoh,et al.  Age‐dependent telomere‐shortening is repressed by phosphorylated α‐tocopherol together with cellular longevity and intracellular oxidative‐stress reduction in human brain microvascular endotheliocytes , 2007, Journal of cellular biochemistry.

[6]  M. Traber,et al.  Vitamin E, antioxidant and nothing more. , 2007, Free radical biology & medicine.

[7]  K. Santacruz,et al.  Apolipoprotein e deficiency leads to altered brain uptake of alpha tocopherol injected into lateral cerebral ventricles. , 2007, Biochimica et biophysica acta.

[8]  A. Azzi Molecular mechanism of α-tocopherol action , 2007 .

[9]  C. di Ilio,et al.  Proteome analysis of human follicular fluid. , 2006, Biochimica et biophysica acta.

[10]  W. Ngah,et al.  Comparative effects of α-tocopherol and γ-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes , 2006, Journal of the Neurological Sciences.

[11]  W. Streit,et al.  Alpha‐tocopherol (vitamin E) induces rapid, nonsustained proliferation in cultured rat microglia , 2006, Glia.

[12]  M. Krieger,et al.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL , 2006, Journal of Molecular Medicine.

[13]  E. Christensen,et al.  Renal albumin absorption in physiology and pathology. , 2006, Kidney international.

[14]  A. Azzi,et al.  α-Tocopheryl phosphate: A novel, natural form of vitamin E , 2005 .

[15]  F. Kronenberg,et al.  Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. , 2005, Journal of proteome research.

[16]  P. Risold,et al.  Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Z. Balázs,et al.  Uptake and transport of high‐density lipoprotein (HDL) and HDL‐associated α‐tocopherol by an in vitro blood–brain barrier model , 2004, Journal of neurochemistry.

[18]  A. Larue,et al.  Differential distribution of cubilin and megalin expression in the mouse embryo. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[19]  H. Arai,et al.  Vitamin E and transfer proteins , 2003, Current opinion in lipidology.

[20]  Florian Kronenberg,et al.  Characterization of the vitamin E-binding properties of human plasma afamin. , 2002, Biochemistry.

[21]  R. Zechner,et al.  Effects of Lipoprotein Lipase on Uptake and Transcytosis of Low Density Lipoprotein (LDL) and LDL-associated α-Tocopherol in a Porcine in Vitro Blood-Brain Barrier Model* , 2002, The Journal of Biological Chemistry.

[22]  T. Willnow,et al.  Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3 , 2002, Current opinion in lipidology.

[23]  A. Rigotti,et al.  Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. , 2002, The Journal of nutrition.

[24]  K. Jishage,et al.  Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: Model for neuronal degeneration caused by chronic oxidative stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. R. van der Westhuyzen,et al.  Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL‐associated vitamin E , 2001, Journal of neurochemistry.

[26]  M. Kiyosawa,et al.  Postmortem study of ataxia with retinitis pigmentosa by mutation of the α-tocopherol transfer protein gene , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  C. Finch,et al.  Glycoprotein 330/Megalin (LRP-2) Has Low Prevalence as mRNA and Protein in Brain Microvessels and Choroid Plexus , 1999, Experimental Neurology.

[28]  N. Bouslam,et al.  Vitamin E deficiency ataxia associated with adenoma , 1999, Journal of the Neurological Sciences.

[29]  P. Labauge,et al.  [Friedreich's ataxia and hereditary vitamin E deficiency. Case study]. , 1998, Revue neurologique.

[30]  H. Galla,et al.  Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. , 1998, Biochemical and biophysical research communications.

[31]  M. Koenig,et al.  Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. , 1998, American journal of human genetics.

[32]  L. Fenart,et al.  A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.

[33]  B. Altura,et al.  α-Tocopherol attenuates alcohol-induced cerebral vascular damage in rats: possible role of oxidants in alcohol brain pathology and stroke , 1996, Neuroscience Letters.

[34]  C. Goetz,et al.  Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients , 1996, Neurology.

[35]  E. Matsubara,et al.  Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Jauhiainen,et al.  Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. , 1995, The Biochemical journal.

[37]  M. Wurfel,et al.  Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. , 1994, The Journal of biological chemistry.

[38]  G. Gyapay,et al.  Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping , 1993, Nature genetics.

[39]  M. Traber,et al.  Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. , 1993, Journal of lipid research.

[40]  H. Esterbauer,et al.  Antioxidants and resistance against oxidation of porcine LDL subfractions. , 1990, Journal of lipid research.

[41]  H. Schrenk,et al.  Radioiodination of proteins and lipoproteins using N-bromosuccinimide as oxidizing agent. , 1988, Analytical biochemistry.

[42]  G. Vatassery,et al.  Vitamin E Concentrations in the Brains and Some Selected Peripheral Tissues of Selenium‐Deficient and Vitamin E‐Deficient Mice , 1984, Journal of neurochemistry.

[43]  A. Azzi Molecular mechanism of alpha-tocopherol action. , 2007, Free radical biology & medicine.

[44]  A. Hammer,et al.  Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. , 2006, The international journal of biochemistry & cell biology.

[45]  M. Mazlan,et al.  Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. , 2006, Journal of the neurological sciences.

[46]  M. Becker‐André,et al.  Vitamin E binding protein afamin protects neuronal cells in vitro. , 2002, Journal of neural transmission. Supplementum.

[47]  W. Argraves,et al.  Cubilin and megalin: partners in lipoprotein and vitamin metabolism. , 2001, Trends in cardiovascular medicine.

[48]  R. Stocker,et al.  Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. , 1994, Methods in enzymology.